Meta-Analysis of Amlodipine for Iron Overload in Thalassemia Major

A systematic review and meta-analysis of three randomized clinical trials involving 130 patients with thalassemia major. The study, authored by Sherief Ghozy, investigates the adjuvant use of amlodipine with chelating agents to reduce iron overload, measuring outcomes like liver iron concentration, serum ferritin, and heart T2*. The results suggest the current evidence for amlodipine's role is inconclusive, with a simulation indicating more data is needed for a definitive answer.

Use Cases

• Assessing the efficacy of amlodipine as an adjuvant therapy based on liver iron concentration (LIC) outcomes.
• Evaluating changes in serum ferritin levels from clinical trial data.
• Analyzing heart T2* measurements to assess cardiac iron overload.
• Conducting power analysis or designing future studies based on the simulation of required sample sizes.

Strengths

• Analysis is based on three randomized clinical trials, a key standard for medical evidence.
• Includes 130 patient records, providing a quantifiable sample size.
• Reports specific statistical measures including mean differences, confidence intervals, and p-values for multiple outcomes.

Limitations

• The meta-analysis found no statistically significant differences for the measured outcomes, limiting conclusive findings.
• The dataset's underlying structure, including column names and individual patient data, is unknown.
• The sample size of 130 patients across three studies may be limited for detecting smaller effect sizes.

Provenance

Source

paperswithcode

Collection Method

Systematic search through 12 databases, followed by meta-analysis of included randomized clinical trials.